Literature DB >> 2483619

Epitope location of 13 anti-gag HIV-1 monoclonal antibodies using oligopeptides and their cross reactivity with HIV-2.

R B Ferns1, J C Partridge, R P Spence, N Hunt, R S Tedder.   

Abstract

A series of 15-mer oligopeptides which overlapped by five amino acids (AA) across the p24 of HIV-1SF2 and a similar series across the p18 of HIV-1SF2 were used to identify the locations of 13 anti-gag monoclonal antibodies (MAbs). Three anti-p24 MAbs recognized sequences within the first 50 AA of the amino-terminal. Another anti-p24 recognized a conformational epitope in the centre of the protein and this MAb cross-reacted with two HIV-2 isolates suggesting conservation of this epitope between HIV-1 and HIV-2. One anti-p24 MAb recognized a linear sequence in the carboxy-terminal 100 AA and one p24 antibody was assumed to recognize a truly conformational epitope as it did not react with any of the linear peptides. Four anti-p18 MAbs were located at the carboxy-terminus of p18 with another MAb mapping slightly inwards from the carboxy-terminus and one anti-p18 MAb failed to bind to the p18 peptides. The carboxy-terminal distribution of the p18 MAbs indicated a highly immunogenic nature for this region in mice. None of the anti-p18 MAbs showed cross-reactivity with HIV-2 isolates, confirming the greater sequence variability of p18 over p24.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2483619     DOI: 10.1097/00002030-198912000-00008

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  11 in total

1.  Characterization of the antigenic domains of the major core protein (p26) of equine infectious anemia virus.

Authors:  Y H Chong; S L Payne; C J Issel; R C Montelaro; K E Rushlow
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

2.  Two immunodominant domains of gp41 bind antibodies which enhance human immunodeficiency virus type 1 infection in vitro.

Authors:  W E Robinson; M K Gorny; J Y Xu; W M Mitchell; S Zolla-Pazner
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: effects on infectivity and neutralization.

Authors:  J A McKeating; A McKnight; J P Moore
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

4.  In vitro assessment of compounds for anti-HIV activity.

Authors:  C Patience; J Moore; M Boyd
Journal:  Mol Biotechnol       Date:  1994-02       Impact factor: 2.695

5.  Characterization of monoclonal antibodies against the human immunodeficiency virus matrix protein, p17gag: identification of epitopes exposed at the surfaces of infected cells.

Authors:  F Shang; H Huang; K Revesz; H C Chen; R Herz; A Pinter
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

6.  Characterization of murine monoclonal antibodies directed against the core proteins of human immunodeficiency virus types 1 and 2.

Authors:  M Niedrig; J Hinkula; H P Harthus; M Bröker; L Hopp; G Pauli; B Wahren
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

7.  A longitudinal study of the IgG antibody response to HIV-1 p17 gag protein in HIV-1+ patients with haemophilia: titre and avidity.

Authors:  D Chargelegue; C M O'Toole; B T Colvin
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

8.  DDX17 Specifically, and Independently of DDX5, Controls Use of the HIV A4/5 Splice Acceptor Cluster and Is Essential for Efficient Replication of HIV.

Authors:  Nyaradzai Sithole; Claire A Williams; Aisling M Vaughan; Julia C Kenyon; Andrew M L Lever
Journal:  J Mol Biol       Date:  2018-07-02       Impact factor: 5.469

9.  Super-resolution microscopy reveals specific recruitment of HIV-1 envelope proteins to viral assembly sites dependent on the envelope C-terminal tail.

Authors:  Walter Muranyi; Sebastian Malkusch; Barbara Müller; Mike Heilemann; Hans-Georg Kräusslich
Journal:  PLoS Pathog       Date:  2013-02-28       Impact factor: 6.823

10.  Association of VH4-59 Antibody Variable Gene Usage with Recognition of an Immunodominant Epitope on the HIV-1 Gag Protein.

Authors:  Valentine U Chukwuma; Mark D Hicar; Xuemin Chen; Katherine J Nicholas; Amanda Joyner; Spyros A Kalams; Gary Landucci; Donald N Forthal; Paul W Spearman; James E Crowe
Journal:  PLoS One       Date:  2015-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.